Egyptian Journal of Medical Human Genetics

Table 3 Comparison between the AML patients and controls regarding WT1 expression

From: Wilms tumor 1 gene expression in acute myeloid leukemia: prognostic significance and usefulness in minimal residual disease monitoring—a case–control study

NCN of WT1 gene expression	AML patients (n = 40)	Controls (n = 15)
Min.–Max	33.0–74,741.0	5.0–1059.0
Mean ± SD	11,109.3 ± 13,387.3	262.13 ± 355.6
Median	7294.0	69.0
IQR	3084.5–14,272.0	35.0–390.0
Significance	p < 0.001

p: p value for Mann Whitney test for comparing Group I and group II
Statistically significant at p ≤ 0.05

Back to article page